Predict your next investment

Deep Chand Dialysis Centre company logo
HEALTHCARE | Medical Facilities & Services / Hospitals

See what CB Insights has to offer


Series C | Alive

Total Raised


Last Raised

$20.59M | 6 mos ago

About Deep Chand Dialysis Centre

Operator of kidney dialysis centers. The company offers specialized diets, patient counseling services, nephrology consultations and transplant clinic services, preventive nephrology, incentre haemodialysis, nocturnal incentre haemodialysis, peritoneal dialysis, and home and mobile dialysis to patients suffering from end stage renal diseases. It currently has 14 centers with a total capacity of around 135-140 beds in India.

Deep Chand Dialysis Centre Headquarter Location

C-185, First Floor Mayapuri industrial area, Phase - 2

New Delhi, 110064,


91 11 4558 1006

Latest Deep Chand Dialysis Centre News

Danish development finance institution leads Series C round in dialysis firm DCDC

Feb 3, 2021

By SHARE DCDC Health Services Pvt. Ltd, which operates dialysis centres under the brand Deep Chand Dialysis Centre, on Wednesday said that it has closed its Series C funding round of Rs 150 crore ($20.5 million). The funding was led by Investment Fund for Developing Countries (IFU), a development finance institution of Denmark, said DCDC in a statement. IFU’s investment has been made on behalf of the Danish SDG Investment Fund, which is backed by Denmark, large Danish pension funds and other private and institutional investors. Existing investor Asian Development Bank (ADB) also participated in this funding round. DCDC will use the funds to expand presence across the country with a mix of public and private partnerships (PPP). The company currently has more than 100 centres with its presence concentrated in the northern regions of Uttar Pradesh, Haryana, National Capital Region (NCR) and Madhya Pradesh. It aims to have over 200 centres over the next three years. Investment bank Veda Corporate Advisors was the exclusive financial adviser to DCDC on the deal. DCDC was founded by Aseem Garg in 2009. It offers dialysis care at its PPP centres along with its centres at private hospitals and standalone clinics. The company had raised its first external funding of close to $5 million from UK-based CDC Group-backed Pragati India Fund in December 2014. In 2018, ADB had agreed to invest $10 million (Rs 68.7 crore) in DCDC. The market for dialysis treatment in India is dominated by small and local players and there are only a handful of national players to cater to a growing market. The sector got a shot in the arm when the government said in the 2016 budget that funds for the National Dialysis Services Programme will be made available through the PPP mode under the National Health Mission. Dialysis chain NephroPlus is the most heavily funded player in the space in India. The company had attracted $45 million from Investcorp as part of its Series D round of funding in November 2019. In the process, it also gave a full exit to SeaLink Capital, which had invested in 2016, while older investors Bessemer Venture Partners and International Finance Corporation (IFC) retained stakes. Last year, NephroPlus bought a majority stake in a Philippine-based company in its first overseas acquisition. In 2018, NephroPlus acquired DaVita Care India Pvt. Ltd. This was the second major acquisition in the dialysis segment involving a private equity-backed company. In September 2016, Germany’s Fresenius Medical Care AG bought an 85% stake in Indian dialysis services company Sandor Nephro Services Pvt. Ltd, which runs the Sparsh Nephrocare chain, from a group of investors including Tata Capital Healthcare Fund.

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Deep Chand Dialysis Centre Web Traffic

Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Deep Chand Dialysis Centre Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.